CCNB1 and lip and oral cavity carcinoma: Accordingly, butyrate, as an inhibitor of histone deacetylation, inhibits the growth of liver cancer cells via down-regulation of cdc2 and cyclin E and cyclin B1 in oral cancer cells [28,29].